10:34 GMT, Thursday, 27 November 2008
Testosterone gel goes worldwide
A Scottish pharmaceutical firm has concluded a deal to market its testosterone gel across 65 countries.
Borders-based ProStrakan has agreed the exclusive licence for Tostran with Bayer Schering Pharma.
The deal covers Canada, Latin America, the Middle East, Africa, Asia and the Pacific region.
Tostran is a 2% testosterone gel designed to treat men with the condition hypogonadism, caused by testosterone deficiency.
Under the terms of the agreement, ProStrakan will receive undisclosed upfront and milestone payments subject to achieving certain sales targets.
Low testosterone levels are associated with symptoms such as reduced energy levels, moodiness, low libido and increased risk of osteoporosis and death.
E-mail this to a friend
Related to this story:
'Male menopause' gel is launched
(12 Jun 07 |
Health
)
Male menopause 'is just laziness'
(17 Jul 03 |
Health
)
Male menopause pill 'may be harmful'
(10 Jun 03 |
Health
)
Male menopause fears highlighted
(26 Dec 02 |
Health
)
Low testosterone 'death risk'
(05 Jun 07 |
Health
)
RELATED INTERNET LINKS
ProStrakan
Bayer Schering Pharma
BBC Guide - Male Menopause
The BBC is not responsible for the content of external internet sites
News Front Page
|
Africa
|
Americas
|
Asia-Pacific
|
Europe
|
Middle East
|
South Asia
|
UK
|
Business
|
Health
|
Science & Environment
|
Technology
|
Entertainment
|
Also in the news
|
Have Your Say
|
UK Contents:
England
|
Northern Ireland
|
Scotland
|
Wales
|
UK Politics
|
Education
|
Magazine
NewsWatch | Notes | Contact us | About BBC News | Profiles | History
~RS~q~RS~~RS~z~RS~08~RS~)